Mallinckrodt (MNK) Tops Q4 EPS by 26c, FY EPS Guidance Beats

Mallinckrodt (NYSE: MNK) reported Q4 EPS of $2.18, $0.26 better than the analyst estimate of $1.92. Revenue for the quarter came in at $834.9 million versus the consensus estimate of $636.61 million.

GUIDANCE:

Mallinckrodt sees FY2019 EPS of $8.10-$8.40, versus the consensus of $7.37.

• Total net sales for Specialty Brands segment Increase 1% to 4%
• Total net sales for Specialty Generics and Amitiza segment Increase 1% to 4%

For earnings history and earnings-related data on Mallinckrodt (MNK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c